Oxford BioDynamics (OBD) Competitors GBX 1.20 -0.05 (-4.23%) (As of 12/20/2024 12:06 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades OBD vs. NSCI, ONC, SNG, BVX, APTA, CIZ, FAB, ROQ, IXI, and GENFShould you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include NetScientific (NSCI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), Aptamer Group (APTA), Cizzle Biotechnology (CIZ), Fusion Antibodies (FAB), Roquefort Therapeutics (ROQ), IXICO (IXI), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry. Oxford BioDynamics vs. NetScientific Oncimmune Synairgen BiVictriX Therapeutics Aptamer Group Cizzle Biotechnology Fusion Antibodies Roquefort Therapeutics IXICO Genflow Biosciences NetScientific (LON:NSCI) and Oxford BioDynamics (LON:OBD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment. Does the MarketBeat Community prefer NSCI or OBD? Oxford BioDynamics received 33 more outperform votes than NetScientific when rated by MarketBeat users. However, 69.61% of users gave NetScientific an outperform vote while only 60.82% of users gave Oxford BioDynamics an outperform vote. CompanyUnderperformOutperformNetScientificOutperform Votes7169.61% Underperform Votes3130.39% Oxford BioDynamicsOutperform Votes10460.82% Underperform Votes6739.18% Does the media prefer NSCI or OBD? In the previous week, Oxford BioDynamics had 1 more articles in the media than NetScientific. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for NetScientific. Oxford BioDynamics' average media sentiment score of 0.92 beat NetScientific's score of 0.00 indicating that Oxford BioDynamics is being referred to more favorably in the news media. Company Overall Sentiment NetScientific Neutral Oxford BioDynamics Positive Do insiders & institutionals have more ownership in NSCI or OBD? 14.7% of NetScientific shares are held by institutional investors. Comparatively, 44.3% of Oxford BioDynamics shares are held by institutional investors. 42.4% of NetScientific shares are held by company insiders. Comparatively, 16.8% of Oxford BioDynamics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, NSCI or OBD? NetScientific has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, Oxford BioDynamics has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Is NSCI or OBD more profitable? Oxford BioDynamics has a net margin of 0.00% compared to NetScientific's net margin of -182.91%. NetScientific's return on equity of -13.70% beat Oxford BioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets NetScientific-182.91% -13.70% -9.42% Oxford BioDynamics N/A -266.70%-56.23% Which has preferable valuation and earnings, NSCI or OBD? NetScientific has higher revenue and earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than NetScientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNetScientific£1.45M0.00-£2.64M-£0.11N/AOxford BioDynamics£176K21.26-£11.11M-£0.06-20.00 SummaryNetScientific and Oxford BioDynamics tied by winning 7 of the 14 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBD vs. The Competition Export to ExcelMetricOxford BioDynamicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£3.74M£165.68M£5.14B£1.91BDividend YieldN/A3.64%5.09%5.45%P/E Ratio-20.00115.5190.051,871.08Price / Sales21.2618,531.021,116.25393,610.87Price / Cash3.9812.8743.1028.67Price / Book1.208.594.782.81Net Income-£11.11M-£20.67M£120.31M£155.88M7 Day PerformanceN/A-1.05%-1.92%-2.02%1 Month Performance3.90%174.77%13.65%21.69%1 Year Performance-95.89%134.18%28.34%29.83% Oxford BioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBDOxford BioDynamicsN/AGBX 1.20-4.2%N/A-95.9%£3.74M£176,000.00-20.0045News CoverageGap DownHigh Trading VolumeNSCINetScientificN/AGBX 53.50flatN/AN/A£12.81M£1.45M-486.3626ONCOncimmuneN/AGBX 15.85+8.1%N/A-41.3%£11.75M£1.21M-528.3352Gap UpSNGSynairgenN/AGBX 4.30-3.8%N/A-70.1%£8.66M£79,000.00-144.7334Gap DownBVXBiVictriX TherapeuticsN/AGBX 10+17.6%N/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeAPTAAptamer GroupN/AGBX 0.42+9.9%N/A-69.6%£8.06M£1.03M-4.7837Positive NewsGap DownHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.71-0.3%N/A-14.6%£6.76M£25,000.00-171.004Gap UpFABFusion AntibodiesN/AGBX 6.70+1.5%N/A+53.1%£6.39M£1.14M-157.6348High Trading VolumeROQRoquefort TherapeuticsN/AGBX 4.57+1.6%N/A-45.9%£5.91M£637.00-467.509IXIIXICON/AGBX 11.15-6.1%N/A-13.6%£5.39M£6M-287.5089Gap DownGENFGenflow BiosciencesN/AGBX 1.45-9.2%N/A+7.1%£5.08MN/A-154.005Gap DownHigh Trading Volume Related Companies and Tools Related Companies NSCI Competitors ONC Competitors SNG Competitors BVX Competitors APTA Competitors CIZ Competitors FAB Competitors ROQ Competitors IXI Competitors GENF Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OBD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBD Stock Alerts